Loading organizations...
Sky Medical Technology develops bioelectronic wearable devices enhancing blood circulation, preventing and treating acute and chronic medical conditions. Its core product, the geko™ device, uses nerve stimulation to activate calf muscle pumps, significantly increasing venous and arterial blood flow. This non-invasive, drug-free platform offers clinicians a novel approach to managing vascular health.
Bernard Ross, the Chief Executive Officer, founded the company in 2007. An experienced company builder, Ross established Sky Medical Technology from an insight to create medical devices addressing unmet healthcare needs. His vision centered on pioneering bioelectronic solutions that transcend traditional therapeutic limitations, leveraging his entrepreneurial background.
The company primarily serves clinicians seeking effective, non-pharmacological interventions. Sky Medical Technology's vision redefines vascular-related condition management, emphasizing improved lower leg and foot care. They aim to enhance healing, prevent complications, and make advanced bioelectronic medicine broadly accessible, transforming patient outcomes.
Sky Medical Technology has raised $29.0M across 2 funding rounds.
Sky Medical Technology has raised $29.0M in total across 2 funding rounds.
Sky Medical Technology has raised $29.0M in total across 2 funding rounds.
Sky Medical Technology's investors include Deepbridge Capital.
Sky Medical Technology has raised $29.0M across 2 funding rounds. Most recently, it raised $14.0M Series B in August 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2017 | $14M Series B | — | Deepbridge Capital | Announced |
| Jan 1, 2015 | $15M Series A | — | Deepbridge Capital | Announced |
Sky Medical Technology is a UK-based medtech company that develops a bioelectronic wearable (the geko™) which uses neuromuscular electrostimulation to increase blood flow and treat or prevent vascular‑related conditions such as DVT, oedema and chronic wound (leg ulcer) healing[1][4]. The company sells into hospitals, outpatient and specialty markets worldwide via direct sales and distributors and has regulatory clearances including multiple FDA clearances and NICE recognition for its device use cases[1][4].
High‑Level Overview
For a portfolio company (product view)
Origin Story
Core Differentiators
Role in the Broader Tech & Healthcare Landscape
Quick Take & Future Outlook
Quick take: Sky Medical Technology has built a clinician‑focused bioelectronic platform with demonstrated regulatory approvals and global reach; its future hinge points are continued evidence generation, reimbursement uptake, and scaling commercial adoption across clinical pathways where non‑invasive circulation enhancement provides clear clinical and economic benefit[1][4][5].
(Claims above are drawn from Sky Medical’s company site and industry reporting summarising the company’s technology, regulatory status, founding/funding approach and commercial expansion[1][2][4][5][6].)